Quantcast

Latest Intrexon Corporation Stories

2014-09-05 16:23:19

GERMANTOWN, Md., Sept. 5, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that, pursuant to the terms of its recent acquisition of Trans Ova Genetics, L.C., an industry-leading provider of bovine reproductive technologies, Intrexon filed a registration statement on Form S-3ASR and prospectus supplement covering the possible resale, from time to time, of shares of Intrexon's common stock received by former shareholders of Trans...

2014-09-05 08:24:07

BLACKSBURG, Va., Sept. 5, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Keith Canada, Ph.D., as Vice President, UltraVector(®) Division, effective September 15. He will report to Chief Operating Officer Krish Krishnan. Dr. Canada's recruitment coincides with the recent introduction of the BeyondBio((TM)) portal, which further expands the accessibility of Intrexon's UltraVector(® )platform to its diverse...

2014-09-02 08:30:38

SAN CARLOS, Calif., Sept. 2, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has entered into an Exclusive Channel Collaboration (ECC) with Sanofi Chimie, a wholly owned subsidiary of Sanofi (EURONEXT: SAN and NYSE: SNY) to develop an enhanced production process for a specific family of its marketed Active Pharmaceutical Ingredients (APIs) through Sanofi's current manufacturing operations in France. This collaboration will...

2014-08-14 16:27:08

GERMANTOWN, Md., Aug. 14, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its second quarter and first half results for 2014. Business Highlights and Recent Developments: -- Acquired Trans Ova Genetics, L.C. ("Trans Ova"), an industry-leading provider of bovine reproductive technologies and the largest producer and supplier of bovine embryos in the United States. The combined technologies of Intrexon and...

2014-08-12 08:30:43

GERMANTOWN, Md., Aug. 12, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON) today announced it will release first half and second quarter 2014 financial results after the market closes on Thursday, August 14(th), 2014. The Company will host a conference call at 5:30 PM ET to discuss the results and provide a general business update. http://photos.prnewswire.com/prnvar/20130919/NY83283LOGO The conference call may be accessed by dialing 1-877-870-4263 (Domestic US) and...

2014-08-11 08:28:46

PRINCETON, N.J., Aug. 11, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today its financial results for the second quarter and six months ended June 30, 2014. Soligenix's revenues for the quarter and six months ended June 30,...

2014-08-11 08:24:10

Completes Acquisition of Trans Ova GERMANTOWN, Md. and SIOUX CENTER, Iowa, Aug. 11, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has completed the acquisition of Trans Ova Genetics, L.C., an industry-leading provider of bovine reproductive technologies. Trans Ova, as a wholly owned subsidiary of Intrexon, will continue to provide the same level of professional service and dedication to its customers operating under the...

2014-08-04 08:28:41

GERMANTOWN, Md., Aug. 4, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that Robert Walsh, Senior Vice President of Intrexon's Energy Sector, will present at the Jefferies 2014 Global Industrials Conference in New York City on Monday, August 11(th) at 2:30PM ET. http://photos.prnewswire.com/prnvar/20130919/NY83283LOGO The presentation materials will be made available on Intrexon's website in the Investors section. About...

2014-07-29 08:32:52

BeyondBio(TM) Platform Enhances The Design and Engineering Process of Biological Solutions GERMANTOWN, Md., July 29, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, has further enhanced its collaboration with a global animal health company to enable remote access to Intrexon's suite of technologies via its groundbreaking BeyondBio(TM) platform. http://photos.prnewswire.com/prnvar/20130919/NY83283LOGO Dana Di Ferdinando, Intrexon's Chief...

2014-07-01 16:30:27

Trans Ova Platform Combined with Intrexon's Technologies to Advance Cattle Genetics SIOUX CENTER, Iowa and GERMANTOWN, Md., July 1, 2014 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into a definitive agreement to acquire Trans Ova Genetics, L.C., an industry-leading provider of bovine reproductive technologies. Trans Ova's dedication and strong commitment to its customers, which has sustained its outstanding...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'